Objective:
Inhibitor development is the most serious complication of hemophilia A therapy. Immune tolerance induction (ITI) is the gold standard for inhibitor eradication, restoring factor VIII (FVIII) responsiveness.…
Did you miss the May 5th Wednesday Webinar? You can view it here and listen to Robert Sidonio, MD discuss the new VWD Guidelines and the most significant changes that healthcare providers and people with VWD should understand. This webinar is…
Hemophilia Treatment Centers (HTCs) across the United States are participating in the 2021 National HTC Patient Satisfaction Survey. If you, or someone you care for, had contact with the HTC in 2020, they want to hear from you! You can take the…
You may be eligible for lower-cost health coverage under the American Rescue Plan (ARP) law enacted in March 2021. If you buy your own health insurance (on- or off-Marketplace), or if you have recently lost your job, you may qualify for substantial…
Heavy Menstrual Bleeding Impact on Mental Health in Adolescent and Young Adult Women with Bleeding Disorders
Speaker: Angela Weyand, MD
Did you miss the May 12th Wednesday Webinar series? If so you can view it here and…
Post-partum Hemorrhage in Women with Bleeding Disorders
Speaker: Homa K. Ahmadzia, MD, MPH
Did you miss the May 19th Wednesday Webinar series? If so click here and listen to Homa K. Ahmadzia, MD, MPH discuss Post-partum…
The New VWD Guidelines: Management
Speaker: Veronica Flood, MD
Did you miss the May 26th Wednesday Webinar series? If so click here to listen to Veronica Flood, MD of the Medical College of Wisconsin address the…
Findings from a recently published study in the Journal of Anesthesia suggest that pregnant patients with hemophilia whose factor VIII or IX levels drop below 50% at the time of receiving neuraxial anesthesia are more likely to experience postpartum…
We invite you to join the quarterly board of directors meeting for the National Hemophilia Foundation on May 27, 2021 07:00 PM Eastern Time . This meeting will discuss NHF business operations and decisions and is open to the public. Join…
The new joint clinical practice guidelines on the diagnosis and management of von Willebrand disease, developed by the American Society of Hematology (ASH), the International Society of Thrombosis and Haemostasis (ISTH), the National Bleeding…